scholarly journals Serial optical coherence tomography findings after drug-coated balloon treatment in de novo coronary bifurcation lesion

2020 ◽  
Vol 27 (4) ◽  
pp. 429-430
Author(s):  
Eun Jung Jun ◽  
Song Lin Yuan ◽  
Scot Garg ◽  
Eun-Seok Shin
Keyword(s):  
Optical Coherence Tomography ◽  
De Novo ◽  
Optical Coherence ◽  
Coronary Bifurcation ◽  
Bifurcation Lesion ◽  
Coronary Bifurcation Lesion ◽  
Drug Coated Balloon

scholarly journals OPTIMAL STRATEGY FOR SIDE BRANCH STENTING IN CORONARY BIFURCATION LESION

2012 ◽  
Vol 59 (13) ◽  
pp. E84
Author(s):  
Young Bin Song ◽  
Joo–Yong Hahn ◽  
Jin–Ho Choi ◽  
Seung–Hyuk Choi ◽  
Hyeon–Cheol Gwon
Keyword(s):  
Optimal Strategy ◽  
Side Branch ◽  
Coronary Bifurcation ◽  
Bifurcation Lesion ◽  
Coronary Bifurcation Lesion

scholarly journals Stentless Strategy by Drug-Coated Balloon Angioplasty following Directional Coronary Atherectomy for Left Main Bifurcation Lesion

2021 ◽  
Vol 2021 ◽  
pp. 1-7
Author(s):  
Norihiro Kobayashi ◽  
Masahiro Yamawaki ◽  
Shinsuke Mori ◽  
Masakazu Tsutsumi ◽  
Yohsuke Honda ◽  
...  
Keyword(s):  
De Novo ◽  
Artery Bypass ◽  
The Other ◽  
Bleeding Complications ◽  
Left Main ◽  
Other Hand ◽  
Bifurcation Lesion ◽  
Bifurcation Lesions ◽  
Directional Coronary Atherectomy ◽  
Drug Coated Balloon

Aims. We aimed to evaluate the efficacy of stentless strategy by drug-coated balloon (DCB) angioplasty following directional coronary atherectomy (DCA) for left main (LM) bifurcation lesions. Methods. A total of 38 patients who underwent DCB angioplasty following DCA for LM bifurcation lesions were retrospectively enrolled. The primary endpoint was target vessel failure (TVF) at 12 months. Secondary endpoints included procedure-related major events during the hospitalization, major adverse cardiac events at 12 months, ischemia-driven target lesion revascularization (TLR) at 12 months, and bleeding complications defined as the Bleeding Academic Research Consortium criteria ≥2 at 12 months. Results. Among these 38 lesions, 31 lesions were de novo LM bifurcation lesions and 7 lesions were stent edge restenosis at the left anterior descending (LAD) ostium. The mean % plaque area (%PA) after DCA was 44.0 ± 7.4%. TVF at 12 months occurred in 1 lesion (3.2%) of de novo LM bifurcation lesion and in 3 lesions (42.9%) of stent edge restenosis at the LAD ostium. All events of TVF were ischemia-driven TLR by percutaneous coronary intervention. Among 4 TLR cases, %PA after DCA was high (55.9%) in the de novo LM bifurcation lesions; on the other hand, %PA after DCA was low (42.4%, 38.7%, and 25.7% in the 3 cases) in stent edge restenosis at the LAD ostium. No procedure-related major events were observed during hospitalization. There was no cardiac death, no myocardial infarction, no coronary artery bypass grafting, and no bleeding complications at 12 months. Conclusions. Stentless strategy by DCB angioplasty following DCA for de novo LM bifurcation lesions resulted in acceptable outcomes. On the other hand, its efficacy was limited for stent edge restenosis at the LAD ostium even after aggressive debulking by DCA.

scholarly journals Coronary Bifurcation Lesion–Management

2020 ◽  
Vol 5 (02) ◽  
pp. 137-154
Author(s):  
Maddury Jyotsna
Keyword(s):  
Management Strategy ◽  
Cardiac Events ◽  
Coronary Bifurcation ◽  
Bifurcation Lesion ◽  
Adverse Cardiac Events ◽  
Drug Eluting ◽  
Bifurcation Lesions ◽  
Coronary Bifurcation Lesion ◽  
Modern Era

AbstractCoronary bifurcation lesion management is challenging even in this modern era of drug-eluting stents (DES). A debate always exists as to what mode of treatment is better–one-stent or two-stent strategy. As in hospital and major adverse cardiac events (MACE) are more in the follow-up, what improvements in management strategy are required in relation to bifurcation lesions? We have more questions than answers for this type of lesion. In this article, we try to analyze these issues.

Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis

2020 ◽  
Vol 21 (4) ◽  
pp. 508-513
Author(s):  
Jose M. de la Torre Hernández ◽  
Tamara Garcia Camarero ◽  
Fernando Lozano Ruiz-Poveda ◽  
Cristóbal A. Urbano-Carrillo ◽  
Ignacio Sánchez Pérez ◽  
...  
Keyword(s):  
Optical Coherence Tomography ◽  
Optical Coherence ◽  
Stent Restenosis ◽  
Drug Coated Balloon ◽  
In Stent Restenosis

scholarly journals Crush Stenting With Drug-Eluting Stents: Relevance of Coronary Bifurcation Lesion Location on Angiographic and Clinical Outcomes

2010 ◽  
Vol 33 (12) ◽  
pp. E32-E39 ◽  
Author(s):  
Shao-Liang Chen ◽  
Jun-jie Zhang ◽  
Fei Ye ◽  
Zhi-zhong Liu ◽  
Zhong-sheng Zhu ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Drug Eluting Stents ◽  
Coronary Bifurcation ◽  
Lesion Location ◽  
Bifurcation Lesion ◽  
Drug Eluting ◽  
Coronary Bifurcation Lesion
Sign in / Sign up

Export Citation Format

Share Document